ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 85 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2014. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $152,000 | -51.0% | 27,749 | -25.7% | 0.01% | -50.0% |
| Q4 2015 | $310,000 | +206.9% | 37,340 | -2.0% | 0.01% | +300.0% |
| Q3 2014 | $101,000 | -34.0% | 38,107 | +0.5% | 0.00% | -25.0% |
| Q2 2014 | $153,000 | +135.4% | 37,908 | +167.6% | 0.00% | +100.0% |
| Q1 2014 | $65,000 | – | 14,164 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 10,986,258 | $20,544,000 | 1.80% |
| Third Security, LLC | 4,364,080 | $8,161,000 | 1.11% |
| MILLER VALUE PARTNERS, LLC | 9,264,700 | $16,617,000 | 0.75% |
| Sargent Investment Group, LLC | 188,950 | $353,000 | 0.22% |
| Chessman Wealth Strategies RIA | 72,050 | $135,000 | 0.14% |
| Ibex Investors LLC | 403,650 | $755,000 | 0.12% |
| Old West Investment Management, LLC | 223,319 | $417,000 | 0.11% |
| PIPER SANDLER & CO. | 34,222 | $64,000 | 0.07% |
| Virtus ETF Advisers LLC | 102,888 | $192,000 | 0.03% |
| G&S Capital LLC | 18,000 | $34,000 | 0.03% |